PCSK9 promotes intestinal overproduction of apolipoprotein-b lipoproteins through ldl-receptor dependent and independent mechanisms von Rashid, S., MD, Tavori, H., MD, Guinzioni, I., MD, Fazio, S., MD

Volltext

PCSK9 inhibition augments the therapeutic effect of ezetimibe in lowering intestinal apolipoprotein B lipoprotein production von Rashid, S., MD, Melone, M., MD, Tavori, H., MD, Guinzioni, I., MD, Neff, D., MD, Fazio, S., MD

Volltext

New developments in atherosclerosis: clinical potential of PCSK9 inhibition von Giunzioni, Ilaria, Tavori, Hagai

Volltext

Binding of PCSK9 to circulating LDL: Effect of PCSK9 monoclonal antibodies on the LDL-bound PCSK9? von De Stefano, D., Baragetti, A., Baragetti, A., Macrì, N., Tavori, H., Fazio, S., Catapano, A.L.

Volltext

Toxicity of leucine-containing peptides in Escherichia coli caused by circumvention of leucine transport regulation von Tavori, H, Kimmel, Y, Barak, Z

Volltext

Acetohydroxy acid synthase is a target for leucine containing peptide toxicity in Escherichia coli von Gollop, N, Tavori, H, Barak, Z

Volltext

Development of a novel Guinea Pig model producing transgenerational endothelial transcriptional changes driven by maternal food restriction and a second metabolic insult of high fa... von Le, Hillary H., Hagen, Matthew W., Louey, Samantha, Tavori, Hagai, Thornburg, Kent L., Giraud, George D., Hinds, Monica T., Barnes, Anthony P.

Volltext

Severe reduction in procoagulant factors and massive fibrinolysis in hereditary fructose intolerance (HFI) von Tavori, S., Sharon, R., Tatarsky, I., Gozal, D., Mandel, H.

Volltext